Corticosteroid Meniscectomy Randomized Trial

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

August 1, 2026

Conditions
Osteoarthritis, KneeMeniscus TearMeniscus; DegenerationSynovitis
Interventions
DRUG

Zilretta Injectable Product or Placebo

The purpose of this intervention is to determine the use of extended release steroid knee injection (Zilretta) at the end of the surgery and its effects on your knee pain.In this study Zilretta will be injected intra-operatively for your arthroscopic partial meniscectomy (APM) surgery.Participants will have MRIs x-rays, and provide a sample of the synovial fluid from both knees at the beginning of surgery. This fluid is drained at the beginning of surgery and then usually discarded. Three samples each of blood and urine will be collected over the study period from each participant and sample of joint (synovial tissue) taken. Participants will be asked to answer questions about knee pain.

Trial Locations (2)

44195

Cleveland Clinic Foundation, Cleveland

02115

Bringham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Arthritis Foundation

OTHER

lead

The Cleveland Clinic

OTHER